MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2023 | 64.39M 68.9M | Sales 2024 * | 75.89M 81.21M | Capitalization | 68.22M 73M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.74M | Net income 2024 * | - | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net Debt 2024 * | 103.27 110.52 | EV / Sales 2024 * | 0.9 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.79
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.90% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |